CMI Inc. and Life Molecular Imaging Announce the Reimbursement of the Amyloid-PET Diagnostic Neuraceq® (florbetaben 18F) in Japan
- Written by PR Newswire
![]() |
First Reimbursed Amyloid PET Diagnostic Tool in Japan
TOKYO and BERLIN, Nov. 23, 2023 /PRNewswire/ -- CMI Inc. and Life Molecular Imaging (LMI) are pleased to announce that the amyloid-PET diagnostic Neuraceq® (florbetaben 18F injection) has been approved from the Ministry of Health, Labor, and Welfare to be reimbursed by...















